In this cohort study, midlife hearing loss was linked with smaller brain volumes, faster decline in executive function, and a higher risk of developing dementia, particularly in those carrying the ...
In this cohort study, patients with early-stage, low-grade endometrial cancer who did not undergo hysterectomy, specifically ...
In non-valvular atrial fibrillation (NVAF) patients taking DOACs, adding amiodarone, diltiazem, dronedarone, or verapamil ...
In this cohort of patients with gastric cancer, there was a significantly higher risk of cardiovascular death compared with ...
Ticagrelor led to a smaller 30-day cardiac magnetic resonance (CMR)-defined infarct size than clopidogrel in ...
Diphenhydramine, Sodium Bicarbonate, or Combination for Acute Peripheral Vertigo: A Randomized Clinical Trial 1. In this randomized clinical trial, combination therapy with diphenhydramine and sodium ...
Intensive systolic blood pressure (SBP) management reduces hypertension-mediated retinal microvascular damage in populations ...
All-cause mortality and reduction in major amputations were similar between groups. 2. The rate of target vessel ...
Dexmedetomidine by subcutaneous infusion can safely improve refractory pain and agitated delirium in hospice patients while ...
Prophylactic antibiotics reduced the risk of clinically relevant wound complications but not overall wound complications in women with episiotomies and second-degree tears. Evidence Rating Level: 1 ...
Amryta’s Sodesta gene therapy gains accelerated approval for ALS The Food and Drug Administration has granted accelerated approval to Sodesta, a one-time gene therapy targeting amyotrophic lateral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback